Article Details

The Daily Biotech Pulse: ObsEva Surges On Out-Licensing Deal, EyeGate Appoints New CEO, 2 ...

Retrieved on: 2021-07-27 11:58:50

Tags for this article:

Click the tags to see associated articles and topics

The Daily Biotech Pulse: ObsEva Surges On Out-Licensing Deal, EyeGate Appoints New CEO, 2 .... View article details on HISWAI: https://markets.businessinsider.com/news/stocks/the-daily-biotech-pulse-obseva-surges-on-out-licensing-deal-eyegate-appoints-new-ceo-2-positive-catalysts-for-merck-candel-therapeutics-debuts-1030649705

Excerpt

... CASI Pharmaceuticals, Inc. (NASDAQ:CASI); Cellectis S.A. (NASDAQ:CLLS); Cullinan Oncology, Inc. (NASDAQ:CGEM); CytomX Therapeutics, Inc.

Article found on: markets.businessinsider.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up